top of page

Our Team

1_edited_edited_edited_edited_edited_edi

Co-Founder

Martyn James

smaller crop_edited_edited.jpg

Co-Founder

Dr Jun Young (Charlie) Jeong

20240703_093103_edited_edited.jpg

Partner Programs and Quality Manager

Umar Amir Abdullahi

Sahar Website image_edited_edited.jpg

Research and Programs Associate

Dr Sahar Khayeche

rob-cs-headshot_edited_edited.jpg

Software Engineer

Robert Robinson

Gemini_Generated_Image_fa8cwqfa8cwqfa8c (1).png

Operations Lead

Harrison Bowers

8E6689AE-5A1F-488E-82D0-34CA2A192584_1_105_c_edited_edited.jpg

Programs Lead

Dr Estelle Altazin

Picture - Heena - 2_edited_edited_edited

Research and Impact Evaluation Lead

Heena Tariq

Our Partners

We partner with high-impact organizations to efficiently reach vulnerable populations by layering ORSZ provision onto existing health interventions.

Our Government Partners

Sustainable impact requires deep integration with local health systems. We work in close coordination with the Nigerian health authorities at every level to align with national strategies and ensure long-term community ownership.

kano-sphmb.png
kano-moh.jpg
nphcda.png

Our Advisors

Advisor headshot.png
Dr Zachary Wagner

Dr Zachary Wagner is Associate Professor (Research) of Economics at the University of Southern California, known for his expertise in global health policy and innovative field experiments. Within his research portfolio spanning health financing, behaviour change, and disease prevention, he led a key randomized controlled trial in Uganda, evaluating several community health worker distribution models for ORS and zinc to treat diarrhoea in children under-5, identifying significant potential for increased ORS and zinc uptake.

​

sl-advisor-headshot-500.jpg
Dr Simon Ling

Simon is the Executive Director at High Impact Medicine, a non-profit organization empowering doctors to apply their careers and giving to highly impactful causes.  He has 25 years experience as an academic paediatric gastroenterologist and leader at The Hospital for Sick Children and the University of Toronto. He undertook clinical research studies of infant nutrition and zinc supplementation in South Asia, and of hepatitis B and other liver diseases in North America. He contributed to the development of clinical practice guidelines, including the 2024 World Health Organization guideline for hepatitis B.

photo-coming-soon.png
Jane & Simon Berry

Jane and Simon Berry are founders of ColaLife and a driving force behind the ORS and Zinc Co-pack Alliance (ORSZCA). ColaLife catalysed huge improvements in ORS+zinc usage rates in Zambia through both the private and public sectors. This success led to engaging the WHO on the addition of co-packaged ORS+zinc to the Model Essential Medicines List, and later building ORSZCA to convene stakeholders with the aim of accelerating the uptake of the co-packaging recommendation.

37.png
Patrick Stadler

​Patrick is co-founder and chair of the board of GiveWell-recommended nonprofit, New Incentives. He helped New Incentives scale from to over 100,000 users for their vaccination programme in Nigeria. 

38.png
Joey Savoie

Joey co-founded Charity Entrepreneurship in 2018 and the organisation has since helped launch numerous high-impact nonprofits through its Incubation Program.

Joey previously founded and led Charity Science Health, a global health charity sending SMS reminders for immunisation appointments in India.

Our Supporters

Clear Solutions is proud to be a grantee of the Ultra Philanthropy
Mid-stage Global Health Fund. We are grateful to all of our donors for their diverse and vital support. From the visionary institutional funding that fuels our scale to the dedicated individual contributions that sustain our daily work, every gift is a cornerstone of our collective impact.

image.png

Clear Solutions UK is a registered Charitable Incorporated Organisation in England and Wales (Charity Number 1214767).

​

In the USA, Clear Solutions is a project of Charity Entrepreneurship operating through a fiscal sponsorship with Players Philanthropy Fund, Inc. (Federal Tax ID: 27-6601178, ppf.org/pp), a Texas nonprofit corporation with federal tax-exempt status as a public charity under Section 501(c)(3) of the Internal Revenue Code.

​

Privacy Policy

Follow our work
  • X
  • LinkedIn

Subscribe to our newsletter to receive periodic updates.

Thanks for subscribing!

bottom of page